Here are the latest quarterly results of CONCORD BIOTECH. For more details, see the CONCORD BIOTECH financial fact sheet and CONCORD BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|
Net Sales | Rs m | 1,948 | 2,623 | 2,408 | 3,190 | |
Other income | Rs m | 67 | 81 | 82 | 108 | |
Turnover | Rs m | 2,015 | 2,705 | 2,490 | 3,298 | |
Expenses | Rs m | 1,227 | 1,432 | 1,349 | 1,847 | |
Gross profit | Rs m | 722 | 1,192 | 1,059 | 1,343 | |
Depreciation | Rs m | 130 | 133 | 135 | 137 | |
Interest | Rs m | 8 | 8 | 5 | 5 | |
Profit before tax | Rs m | 650 | 1,132 | 1,001 | 1,309 | |
Tax | Rs m | 165 | 287 | 255 | 337 | |
Profit after tax | Rs m | 485 | 845 | 746 | 972 | |
Gross profit margin | % | 37.0 | 45.4 | 44.0 | 42.1 | |
Effective tax rate | % | 25.4 | 25.3 | 25.5 | 25.7 | |
Net profit margin | % | 24.9 | 32.2 | 31.0 | 30.5 | |
Diluted EPS | Rs | 4.6 | 8.1 | 7.1 | 9.3 | |
Diluted EPS (TTM) | Rs | NA | NA | NA | 29.1 | |
Subscriber Feature |
Asian stocks fell on Friday, while the dollar advanced as strong US economic data bolstered the prospect of interest rates staying higher for longer.